![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CNTN4 |
Gene summary for CNTN4 |
![]() |
Gene information | Species | Human | Gene symbol | CNTN4 | Gene ID | 152330 |
Gene name | contactin 4 | |
Gene Alias | AXCAM | |
Cytomap | 3p26.3-p26.2 | |
Gene Type | protein-coding | GO ID | GO:0000902 | UniProtAcc | A0A024R2E5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
152330 | CNTN4 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.37e-40 | -1.11e+00 | 0.0155 |
152330 | CNTN4 | HTA11_2487_2000001011 | Human | Colorectum | SER | 8.76e-05 | -5.77e-01 | -0.1808 |
152330 | CNTN4 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.44e-15 | -9.79e-01 | -0.0811 |
152330 | CNTN4 | HTA11_78_2000001011 | Human | Colorectum | AD | 6.08e-04 | -5.48e-01 | -0.1088 |
152330 | CNTN4 | HTA11_411_2000001011 | Human | Colorectum | SER | 5.03e-03 | -1.03e+00 | -0.2602 |
152330 | CNTN4 | HTA11_2112_2000001011 | Human | Colorectum | SER | 6.13e-06 | -1.01e+00 | -0.2196 |
152330 | CNTN4 | HTA11_3361_2000001011 | Human | Colorectum | AD | 4.17e-08 | -7.16e-01 | -0.1207 |
152330 | CNTN4 | HTA11_696_2000001011 | Human | Colorectum | AD | 7.78e-35 | -8.34e-01 | -0.1464 |
152330 | CNTN4 | HTA11_866_2000001011 | Human | Colorectum | AD | 3.14e-10 | -5.02e-01 | -0.1001 |
152330 | CNTN4 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.88e-13 | -7.84e-01 | -0.059 |
152330 | CNTN4 | HTA11_2992_2000001011 | Human | Colorectum | SER | 4.59e-11 | -1.20e+00 | -0.1706 |
152330 | CNTN4 | HTA11_5212_2000001011 | Human | Colorectum | AD | 5.32e-14 | -1.26e+00 | -0.2061 |
152330 | CNTN4 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.34e-02 | -6.17e-01 | -0.0842 |
152330 | CNTN4 | HTA11_7862_2000001011 | Human | Colorectum | AD | 6.46e-05 | -6.20e-01 | -0.0179 |
152330 | CNTN4 | HTA11_866_3004761011 | Human | Colorectum | AD | 6.05e-37 | -1.08e+00 | 0.096 |
152330 | CNTN4 | HTA11_4255_2000001011 | Human | Colorectum | SER | 1.43e-03 | -8.22e-01 | 0.0446 |
152330 | CNTN4 | HTA11_9408_2000001011 | Human | Colorectum | AD | 1.33e-06 | -1.21e+00 | 0.0451 |
152330 | CNTN4 | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.23e-06 | -9.42e-01 | 0.0528 |
152330 | CNTN4 | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.21e-19 | -9.34e-01 | 0.0338 |
152330 | CNTN4 | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.10e-52 | -1.09e+00 | 0.0674 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0007409 | Colorectum | AD | axonogenesis | 122/3918 | 418/18723 | 3.36e-05 | 6.15e-04 | 122 |
GO:0061564 | Colorectum | AD | axon development | 132/3918 | 467/18723 | 8.40e-05 | 1.31e-03 | 132 |
GO:0007411 | Colorectum | AD | axon guidance | 64/3918 | 227/18723 | 5.41e-03 | 3.55e-02 | 64 |
GO:0097485 | Colorectum | AD | neuron projection guidance | 64/3918 | 228/18723 | 6.02e-03 | 3.78e-02 | 64 |
GO:00074111 | Colorectum | SER | axon guidance | 51/2897 | 227/18723 | 3.29e-03 | 2.82e-02 | 51 |
GO:00974851 | Colorectum | SER | neuron projection guidance | 51/2897 | 228/18723 | 3.61e-03 | 3.03e-02 | 51 |
GO:00615641 | Colorectum | SER | axon development | 94/2897 | 467/18723 | 3.78e-03 | 3.13e-02 | 94 |
GO:00074091 | Colorectum | SER | axonogenesis | 84/2897 | 418/18723 | 6.20e-03 | 4.49e-02 | 84 |
GO:00074092 | Colorectum | MSS | axonogenesis | 105/3467 | 418/18723 | 4.32e-04 | 5.23e-03 | 105 |
GO:00615642 | Colorectum | MSS | axon development | 115/3467 | 467/18723 | 5.33e-04 | 6.00e-03 | 115 |
GO:00615643 | Colorectum | FAP | axon development | 106/2622 | 467/18723 | 1.98e-07 | 1.21e-05 | 106 |
GO:00074093 | Colorectum | FAP | axonogenesis | 97/2622 | 418/18723 | 2.20e-07 | 1.30e-05 | 97 |
GO:00074094 | Colorectum | CRC | axonogenesis | 81/2078 | 418/18723 | 3.60e-07 | 2.99e-05 | 81 |
GO:00615644 | Colorectum | CRC | axon development | 86/2078 | 467/18723 | 1.48e-06 | 8.12e-05 | 86 |
GO:0050804 | Colorectum | CRC | modulation of chemical synaptic transmission | 70/2078 | 439/18723 | 1.15e-03 | 1.33e-02 | 70 |
GO:0099177 | Colorectum | CRC | regulation of trans-synaptic signaling | 70/2078 | 440/18723 | 1.23e-03 | 1.38e-02 | 70 |
GO:00615646 | Lung | IAC | axon development | 78/2061 | 467/18723 | 1.12e-04 | 2.15e-03 | 78 |
GO:00074096 | Lung | IAC | axonogenesis | 71/2061 | 418/18723 | 1.33e-04 | 2.48e-03 | 71 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CNTN4 | SNV | Missense_Mutation | c.686T>A | p.Val229Glu | p.V229E | Q8IWV2 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-CG-4437-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CNTN4 | SNV | Missense_Mutation | c.463N>A | p.Tyr155Asn | p.Y155N | Q8IWV2 | protein_coding | deleterious(0.03) | probably_damaging(0.996) | TCGA-CG-4441-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
CNTN4 | SNV | Missense_Mutation | rs767479884 | c.2018N>A | p.Arg673His | p.R673H | Q8IWV2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CG-4460-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | capecitabine | PD |
CNTN4 | SNV | Missense_Mutation | c.2769N>C | p.Gln923His | p.Q923H | Q8IWV2 | protein_coding | tolerated(0.51) | benign(0.005) | TCGA-CG-5734-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
CNTN4 | SNV | Missense_Mutation | c.1443N>A | p.Asn481Lys | p.N481K | Q8IWV2 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-D7-6526-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | SD | |
CNTN4 | SNV | Missense_Mutation | c.547N>G | p.Lys183Glu | p.K183E | Q8IWV2 | protein_coding | deleterious(0) | probably_damaging(0.982) | TCGA-F1-6874-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CNTN4 | SNV | Missense_Mutation | rs576375620 | c.407N>A | p.Arg136Gln | p.R136Q | Q8IWV2 | protein_coding | tolerated(0.1) | benign(0.001) | TCGA-HU-A4GF-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
CNTN4 | SNV | Missense_Mutation | rs767370642 | c.1577N>T | p.Ser526Leu | p.S526L | Q8IWV2 | protein_coding | tolerated(0.24) | benign(0.021) | TCGA-MX-A5UJ-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
CNTN4 | SNV | Missense_Mutation | novel | c.82N>C | p.Phe28Leu | p.F28L | Q8IWV2 | protein_coding | deleterious(0.03) | possibly_damaging(0.864) | TCGA-VQ-A8P3-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | CR |
CNTN4 | SNV | Missense_Mutation | novel | c.1249A>G | p.Thr417Ala | p.T417A | Q8IWV2 | protein_coding | tolerated(0.36) | benign(0.403) | TCGA-VQ-A8PP-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |